Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
about
Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancerMagnetic resonance imaging in rectal cancer: a surgeon's perspectiveMagnetic resonance imaging and endorectal ultrasound for diagnosis of rectal lesionsMRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.Transrectal ultrasound and magnetic resonance imaging measurement of extramural tumor spread in rectal cancer.Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging.Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.Total mesorectal excision optimized by pelvic MRI.Pre-operative staging of rectal cancer: a review of imaging techniques.PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging.The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.Extramural venous invasion detected by MDCT as an adverse imaging feature for predicting synchronous metastases in T4 gastric cancer.The prognostic significance of extramural venous invasion detected by multiple-row detector computed tomography in stage III gastric cancer.Extramural vascular invasion detected by contrast-enhanced multiple-row detectors computed tomography (ceMDCT) as a predictor of synchronous metastases in colon cancer.Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: Long-term outcomes of a propensity score matched study.A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases.MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer
P2860
Q27003878-3A79FD65-D311-4158-BF48-206BACA78B20Q27027906-5F3B0955-8E78-46E8-946A-12C264023885Q35005141-BFAB025F-3A3E-490A-B42F-4A8B156E120BQ35885124-F9A0D969-E98E-4D2E-9BC3-837DEA4E9657Q36285755-5D93DD03-16F9-4861-8C18-5F97AF1BFBA5Q37034524-C9315003-4C36-4BB0-B0DA-CFBA5D4D7C19Q37988785-84A11DE6-0FB2-467A-9707-C0DCAA79008AQ38247507-6369C1E9-5719-4126-B3FC-532B69639162Q38827538-25C044BE-979A-4149-8298-D4136E8278E6Q38863195-EEFCF459-1ABA-4007-9329-3E3F7F20DFB5Q38943223-63711070-6C9A-460A-A243-C35B07D08D5CQ40475290-62F6F79B-A5C7-43FB-A5CC-5F3211F4E5A7Q40641195-1C605E19-F6D6-447A-A5A6-2318C62E7051Q40695084-A16C337E-4F34-4844-AA3A-066A297C3A8BQ47150395-5BB34653-5CA4-4A8D-A258-25CCE574D89CQ48169890-027294E8-FAD8-489B-9AAC-ADEC9A374309Q55231489-C3274796-7AAD-4790-A7CC-CFF77BC55E75Q59115806-C2A165C7-C2A4-4330-A28E-8026AAFFDFAE
P2860
Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Adverse features on rectal MRI ...... erative staging and treatment.
@en
Adverse features on rectal MRI ...... erative staging and treatment.
@nl
type
label
Adverse features on rectal MRI ...... erative staging and treatment.
@en
Adverse features on rectal MRI ...... erative staging and treatment.
@nl
prefLabel
Adverse features on rectal MRI ...... erative staging and treatment.
@en
Adverse features on rectal MRI ...... erative staging and treatment.
@nl
P2093
P2860
P1476
Adverse features on rectal MRI ...... erative staging and treatment.
@en
P2093
Aurelie Garant
Chris J Hunter
Giovanni Artho
Muti Abulafi
Paris Tekkis
Robert Lisbona
P2860
P2888
P304
P356
10.1245/S10434-011-2036-1
P50
P577
2011-09-13T00:00:00Z
P6179
1042671381